2615.8000 -17.10 (-0.65%)
NSE Nov 17, 2026 15:31 PM
Volume: 292.7K
 

Geojit BNP Paribas
*over or under performance to benchmark index Glenmark Pharmaceuticals Ltd, which has a presence in over 80 countries, focuses on the generics, specialty and over-the-counter (OTC) segments, with a strong presence in diabetes, cardiovascular and oral contraceptives. In Q4FY26, Glenmark's normalized revenue grew 11.1% YoY to Rs. 3,616cr, driven...
Motilal Oswal increased Buy price target of Glenmark Pharmaceuticals Ltd. to 3000.0 on 07 Nov, 2026.
More from Glenmark Pharmaceuticals Ltd.
Recommended